Lion seeks trans-Atlantic IPO

Lion Bioscience (Heidelberg, Germany) has announced plans to dual list on NASDAQ and the Neuer Markt and to raise EUR169.3-EUR201.3 million ($160.4-$190.7 million). The data management and drug discov...